North America Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The North American Colorectal Cancer Screening Market Report is Segmented by Screening Tests (Stool-Based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Tests), End Users (Hospitals, Diagnostic Centers/Laboratories, and Other End Users), and Geography (United States, Canada, and Mexico).

North America Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Colorectal Cancer Screening Industry Overview

The North American colorectal cancer screening market is fragmented due to the presence of many small and large market players. These market players are involved in various strategic activities such as agreements, partnerships, and developments to increase the product portfolio of the companies in the region. Some key North American colorectal cancer screening market players are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Siemens Healthineers, and Sysmex Corporation.

North America Colorectal Cancer Screening Market Leaders

  1. Abbott Laboratories

  2. Epigenomics Inc.

  3. Exact Sciences Corporation

  4. Clinical Genomics Technologies Pty Ltd.

  5. Hemosure Inc.

  6. *Disclaimer: Major Players sorted in no particular order
North America Colorectal Cancer Screening Market Concentration

North America Colorectal Cancer Screening Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?